The development of an environmentally benign synthesis of sildenafil citrate (Viagra™) and its assessment by Green Chemistry metrics

被引:137
作者
Dunn, PJ [1 ]
Galvin, S
Hettenbach, K
机构
[1] Pfizer Global Res & Dev, Dept Chem Res & Dev, Sandwich CT13 9NJ, Kent, England
[2] Pfizer Ireland Pharmaceut, Ringaskiddy API Plant, Ringaskiddy, Cork, Ireland
[3] Pfizer Global Res & Dev, Dept Chem Res & Dev, Groton, CT 06340 USA
关键词
D O I
10.1039/b312329d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The process development and scale-up of the sildenafil citrate process is reviewed. Key environmental metrics are reported at several time points during the development process. Significant achievements during the development of sildenafil citrate were (i) discovering a convergent, efficient synthetic route (ii) designing 7 process steps so that there was no extractive work-up in any step (iii) implementing efficient solvent recovery early in the product's commercial lifetime. The result of this work is. that the E-factor for the process is very low with just 6 Kg of waste per kilogram of product compared with an industry average of 25-100 Kg. Pfizer received the 2003 UK Award for Green Chemical Technology (Best Process category), for the sildenafil citrate process.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 8 条
[1]  
Bell A. S., 1991, [No title captured], Patent No. [EP0463756 A1, 0463756]
[2]   Metrics to 'green' chemistry - which are the best? [J].
Constable, DJC ;
Curzons, AD ;
Cunningham, VL .
GREEN CHEMISTRY, 2002, 4 (06) :521-527
[3]   So you think your process is green, how do you know? Using principles of sustainability to determine what is green - a corporate perspective [J].
Curzons, AD ;
Constable, DJC ;
Mortimer, DN ;
Cunningham, VL .
GREEN CHEMISTRY, 2001, 3 (01) :1-6
[4]   The chemical development of the commercial route to sildenafil: A case history [J].
Dale, DJ ;
Dunn, PJ ;
Golightly, C ;
Hughes, ML ;
Levett, PC ;
Pearce, AK ;
Searle, PM ;
Ward, G ;
Wood, AS .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (01) :17-22
[5]   SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF PYRAZOLO[4,3-D]PYRIMIDIN-7-ONES AS ADENOSINE RECEPTOR ANTAGONISTS [J].
HAMILTON, HW ;
ORTWINE, DF ;
WORTH, DF ;
BRISTOL, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (01) :91-96
[6]  
SHELDON RA, 1992, CHEM IND-LONDON, P903
[7]  
Sheldon RA, 1997, CHEM IND-LONDON, P12
[8]  
TROST BM, 1991, SCIENCE, V254, P471